'Net sales
(including other operating income) of Bayer CropScience has increased 7.44% to
Rs 1,737.60 crore.
Operating
profit margin has declined from 18.85% to 10.58%, leading to 39.72% decline in
operating profit to Rs 183.80 crore.
Raw
material cost as a % of total sales (net of stock adjustments) increased from
59.29% to 64.21%. Purchase of finished
goods cost rose from 2.11% to 3.05%.
Employee cost increased from 6.40% to 6.95%. Other expenses rose from 12.85% to
14.76%.
Other
income up 47.20% to Rs 23.7 crore.
PBIDT
fell 35.36% to Rs 207.5 crore. Provision
for interest fell 8.11% to Rs 3.4 crore.
Loan funds declined from Rs 63.80 crore as of 30 September 2023 to Rs
33.40 crore as of 30 September 2024.
Pleaselogin & subscribe to view the full report.
More Reports
-
(22-Jan-2025)
Dalmia Bharat
PAT down 76.8% YoY to Rs 61 crore in Q3FY2025
-
Revenue up 16.05% YoY to Rs 354.3 crore in Q3FY2025
-
AUM growth, asset quality and margin improves
-
(22-Jan-2025)
L&T Finance
Retail loan growth healthy at 23%, rural business segment shows high slippages
|
|